FIELD: medicine, pharmacy. SUBSTANCE: invention proposes pharmaceutical compositions containing derivatives of estra-1,3,5(10)-triene as active components which carry in their C3 position the group of the general formula R-SO2- O- where R means the group R1R2N where R1 and R2 mean oxygen atom independently each of other, C1-C5-alkyl radical or in common with nitrogen atom they mean polymethyleneimino-group containing 4-6 carbon atoms or morpholino-group. Compositions are designated for hormonal contraception and hormone substitution therapy and they elicite low estrogen activity with respect to liver. EFFECT: valuable medicinal properties of compositions. 3 cl, 10 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139885C1 |
SULFAMATE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159774C2 |
17β-HSD1 AND STS INHIBITORS | 2006 |
|
RU2412196C2 |
BRIDGE-CONTAINING ESTRATRIENES | 1990 |
|
RU2087479C1 |
15,15-DIALKYLSTEROID COMPOUNDS AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2147306C1 |
INDUSTRIAL METHOD FOR PRODUCTION OF HIGH PURITY ESTETROL | 2020 |
|
RU2802820C2 |
DERIVATIVES OF 11β-BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2137777C1 |
NEW INHIBITORS OF 17 β-HYDROXYSTEROID-DEHYDROGENASE TYPE I | 2004 |
|
RU2369614C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
DERIVATIVES OF 11β--BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130944C1 |
Authors
Dates
2002-02-20—Published
1995-07-03—Filed